Safety Follow-up of Adult Stem Cell Patients Yields Promising Results

Share Article

The XCell-Center has completed a promising safety follow-up of 870 patients who were treated by lumbar puncture for various indications such as spinal cord injury, Parkinson's disease, cerebral palsy, and more. Patients were surveyed 10 days after treatment and again after 3 months.

The XCell-Center has completed a promising safety follow-up of 870 patients who were treated by lumbar puncture for various indications such as spinal cord injury, Parkinson's disease, cerebral palsy, and more. Patients were surveyed 10 days after treatment and again after 3 months.

A lumbar puncture is a procedure by which a patient’s own stem cells are injected into their spinal fluid under local or general anesthesia (mainly in children). Prior to the lumbar puncture, bone marrow is collected from the patient’s iliac crest (hip bone) using thin-needle mini-puncture under local or general anesthesia. The stem cells are then separated from the bone marrow using a proprietary process in a cGMP certified laboratory.

“Overall, we found that the transplantation of stem cells via lumbar puncture appears to as safe as common lumbar puncture procedures used for other purposes such as diagnostics. Therefore, we’ve concluded that lumbar puncture is a safe and non-invasive procedure by which to inject stem cells into a patient's intrathecal space (spinal fluid),” stated Dr. Johannes de Munter, Director Research and Development XCell-Center Cologne and Dusseldorf Germany.

The most common side-effects experienced by patients were headache and backache; occurring in approximately 1 out of 5 patients. The researchers determined that headaches were a relative side effect due to the lumbar puncture procedure itself and were unrelated to the stem cells. Leg pain and nausea were reported by roughly 10% of those treated. 98% of patients reported that their side-effects subsided in less than 10 days.

The Complete results may be viewed here: http://www.xcell-center.com/media/89867/safety%20database%20lp%20febr2010.pdf

About the XCell-Center:
The XCell-Center operates treatment centers in Cologne and Dusseldorf, Germany. It is the first privately-owned clinic in Europe to specialize in regenerative medicine using autologous bone marrow stem cell therapy and operates in accordance with German law, European guidelines and ISO 9001. Its specialized medical team of German physicians includes specialists in: neurosurgery, orthopedics, cardiology, radiology, anesthesiology and pharmacology.

The XCell-Center also treats Diabetes and its complications (Erectile Dysfunction and Peripheral Artery Disease), Stroke, Cerebral Palsy, Autism, Spinal Cord Injuries, Orthopedic diseases, Heart Disease and degenerative diseases such as Multiple Sclerosis, Parkinson's, Alzheimer's and several eye diseases.

For more information on Stem Cell Therapy: XCell-Center Website: http://www.xcell-center.com

XCell-Center GmbH
at the Institute for Regenerative Medicine
Am Heerdter Krankenhaus 2
40549 Dusseldorf, Germany

E-Mail: info(at)xcell-center(dot)de

Phone: 1-866-680-8202 (USA Toll-Free) (+49) 0221-802-5095 (Germany)
Fax: 1-713-583-9322 (USA) (+49) 0221-2921-2550 (Germany)

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jay Lenner
Visit website